TC BioPharm (Holdings) PLC (TCBP)
0.6298
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
0.62
-0.01
(-1.56%)
After-Hours: 07:31
TC BioPharm Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2021 | -0.411 |
| September 30, 2021 | -0.3895 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.411
Minimum
Dec 2021
--
Maximum
Dec 2020
-0.2668
Average
-0.3895
Median
Sep 2021
Debt to Equity Ratio Benchmarks
| Adaptimmune Therapeutics PLC | 0.6234 |
| Biodexa Pharmaceuticals PLC | -- |
| Verona Pharma PLC | 0.9197 |
| NuCana PLC | -- |
| Autolus Therapeutics PLC | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.171M |
| Total Liabilities (Quarterly) | 7.807M |
| Shareholders Equity (Quarterly) | 1.364M |